25 June 2026Merck, the Darmstadt-based science and technology giant, has entered into a definitive agreement to acquire Minneapolis-based Bio-Techne Corporation. This all-cash…- 22 June 2026Listed US-based global biopharmaceutical company AbbVie has agreed to acquire clinical stage biotechnology firm Apogee Therapeutics in an all cash…
- 12 June 2026French private equity firm Motion Equity Partners has acquired a majority stake in Polaris, a Brittany-based biotechnology specialist renowned for…
- 9 June 2026GSK is to acquire Boston-based clinical-stage oncology specialist Nuvalent for an equity value of approximately $10.6bn. This marks the British…
- 1 June 2026Swiss contract development and manufacturing organisation CordenPharma is buying the US-headquartered peptide specialist AmbioPharm. The transaction will significantly bolster the…
- 27 May 2026A consortium led by CVC Capital Partners and Groupe Bruxelles Lambert has launched a voluntary cash tender offer to take…
- 25 May 2026New York-based PE Avista Healthcare Partners and the Belgium-based family office Damier Group have signed a definitive agreement to acquire…
- 18 May 2026Italian pharmaceutical group Angelini Pharma has agreed to acquire Catalyst Pharmaceuticals in an all-cash transaction valued at $4.1bn. The acquisition…
- 6 May 2026Pan-European London-based entrepreneurial private equity firm Columna Capital is acquiring a majority stake in Evidenze from Buenavista Equity Partners.Evidenze is…
- 6 May 2026Germany-based multinational life science company Bayer is to fully acquire San Francisco based biopharmaceutical firm Perfuse Therapeutics for a total…
